StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
LFST.V$0.04+12.50%
Fair $0.04+0.0%

LFST.V

Lifeist Wellness Inc.

Consumer Defensive / Packaged FoodsTSXV

$0.04

+0.01 (+12.50%)

Fairly Valued+0.0%Fair Value $0.04Fund rank 24/100 · Data gapFallback financials|
SA 11/F
F-Score: 2/9
Declining RevenueMargin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-2.5M · quality 35.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

11/100

F

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 3unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 3 consecutive years Operating margin has declined for 3 consecutive years ROE is -2.6%, below the 5% threshold
Thesis & Journal · LFST.VLocal privado en este navegador · Lifeist Wellness Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-260.7%

↓

Gross Margin

23.7%

↓

Debt/Equity

N/A

•
52-Week Range$0
$0$0

TradingView lightweight chart

LFST.V price, volumen y niveles de valoración

Último $0.045Periodo -99.9%
Fair value: $0.045

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-77.6%

FCF CAGR

—

FCF margin

-1162.8%

FCF / Net income

0.97x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $249367.0 · net income $-3.0M · FCF $-2.9M

2022-FY → 2025-FY

Gross margin

23.7%+1.2% pts

Operating margin

-961.1%-894.0% pts

Net margin

-1199.0%-1129.0% pts

FCF margin

-1162.8%-1090.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$249367.00$249367.00$588802.00$1.4M$22.1M
Net Income$-3.0M$-3.0M$-1.4M$-14.1M$-15.4M
EBITDA$-3.0M$-3.0M$-4.0M$-6.0M$-17.4M
EPS-0.08-0.08-0.05-0.25-0.60
Gross Margin23.7%23.7%34.8%55.9%22.5%
Operating Margin-961.1%-961.1%-753.0%-453.3%-67.1%
Net Margin-1199.0%-1199.0%-245.5%-1034.9%-69.9%
Balance Sheet
Debt/Equity———0.370.02
Current Ratio3.333.33———
Cash Flow
Free Cash Flow$-2.9M$-2.9M$-877198.00$-2.5M$-16.0M
Returns
ROE-260.7%-260.7%-35.5%-408.4%-115.5%
Valuation
P/B1.491.490.352.122.18
Growth & Yield
Revenue Growth-57.6%-57.6%-56.9%-93.8%—
EPS Growth-71.7%-71.7%81.4%58.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -40.0%

Total return

-40.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.05 → -0.08

Residual

-40.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-40.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.